China’s drug regulator clears mpox vaccine

Beijing, Sep 10: China’s top drug regulator has cleared a mpox vaccine developed by local drug firm Sinopharm for clinical trials which could be the country’s first experimental dose to battle the deadly disease.

The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to play an important role in preventing and controlling mpox infections, the company said in a statement released on Monday afternoon.

There is currently no approved mpox vaccine in China. Globally, a few vaccines have been approved in the United States, Canada, the European Union, Japan and Russia.

In China, a vaccine candidate typically goes through three phases of clinical trials before gaining market approval.

The process can take years, even decades. However, the National Medical Products Administration, China’s top drug regulator, has launched a number of accelerated or streamlined channels to facilitate applications of novel drugs and vaccines or those in urgent need, state-run China Daily reported on Tuesday.

According to the company, the new vaccine is a replication-deficient vaccine based on a strain called MVA.

The description is the same as Jynneos, the world’s first mpox vaccine approved by the Food and Drug Administration in the United States in 2019.

The World Health Organisation said on August 14 that the mpox outbreak in Africa constitutes a public health emergency of international concern — its highest form of alert.

Previously, in July 2022, the WHO declared a global emergency but then lifted it in May last year because of a sustained decline in international cases.

So far, more than 120 countries and regions across the world have reported more than 100,000 confirmed infections and 226 related deaths.

China reported its first imported case in September 2022 and the first domestic case in June last year.

By the end of July, the nation had reported 2,567 confirmed cases, according to the China Daily report. (PTI)

Hot this week

Pay hike of Assam ministers, MLAs likely as 3-member panel submits report

Full report likely by Oct 30 Guwahati Sept 25: There...

Meghalaya Biological Park Inaugurated After 25 Years: A New Chapter in Conservation and Education

Shillong, Nov 28: Though it took nearly 25 years...

ANSAM rejects Kuki’s separate administration demand, says bifurcation not acceptable

Guwahati, Sept 8: Rejecting the separate administration demand of...

Meghalaya man missing in Bangkok

Shillong, Jan 10: A 57-year-old Meghalaya resident, Mr. Treactchell...

Meghalaya’s historic fiber paves the way for eco-friendly products and sustainable livelihoods

By Roopak Goswami Shillong, Oct 25: From making earbuds to...

J-K Police unmasks major terror-funding network in Delhi; two arrested

Srinagar, Aug 6: The counter-intelligence wing of Jammu and...

Nagaland against separate Constitutional Article for ENPO demand

Kohima, Aug 6: The Nagaland government on Wednesday strongly...

PM Modi expected to visit China

New Delhi, Aug 6: After a gap of over...

GI tags help preserve heritage, empower artisans: Rajani Kant

Shillong, Aug 6: Geographical Indications (GI) are a powerful...

CM directs Health Dept to speed up MHIS payments  

Measures ordered to address delay in payments and claim...

HYC writes to minister on erosion in EKH, says farmland threatened

Shillong, Aug 6: Concerned over the growing threat of...

Group urges CM to fast-track project approval for SWKH road

Shillong, aug 6: A delegation from South West Khasi...

HC satisfied with Govt action to tackle stray dog menace

Shillong, Aug 6: The Meghalaya High Court has expressed...
spot_img

Related Articles

Popular Categories